Product Images Gabapentin

This text provides a table with gabapentin dosage based on renal function, specifically creatinine clearance in mL/min. Different dosage ranges for Total Daily Dose, Dose Range, and Post-Hemodialysis Supplemental Dose (in mg) are given for each range of creatinine clearance. The table also provides the corresponding abbreviations of the frequency of doses: TID (three times a day), BID (two times a day), and QD (single daily dose). The text also includes instructions on how to adjust the dose for patients with creatinine clearance <15 mL/min and patients receiving hemodialysis.*

This text appears to be a formula or equation related to the calculation of creatinine clearance rate (CLCr) for female patients. It involves multiplying a constant value of 140 by the patient's age in years (represented by "g(yeurs)") and then multiplying that result further by their weight in kilograms. This overall result is then multiplied by the patient's serum creatinine level in milligrams per deciliter (mg/dL). The variable "CLCy" likely represents the calculated creatinine clearance rate value.*

This text appears to be a table showing the risk of antiepileptic drugs in comparison to placebo patients. The table includes four indications (epilepsy, psychiatric, other, and total) and shows the number of patients with events per 1000 patients for both placebo patients and drug patients. The relative risk and risk difference are calculated and listed as well.*

The text describes a graph or table showing the Mean Pain Score over the course of a study with two periods: a 4-week dose titration period and a 4-week fixed dose period. The study involved a placebo group and a group taking 3600 mg/day of gabapentin. The x-axis shows the 8 weeks of the study, and the y-axis measures the mean pain score. No further details or context are available.*

The text is describing the results of controlled PHN studies and shows the proportion of patients who responded positively to treatment, with a reduction in pain score greater than 50%. The figure displays the results of Study 1 and Study 2, with Study 1 showing a proportion of responders of 34%, while Study 2 shows a higher proportion of responders. The significance of the results is indicated by the p-value of less than 0.001. Additionally, there are mentions of different dosages of medication (GEP 3600, GBP 1800, GBP 2400), but no details are provided about their use or effect.*

This text contains information about a medication called Gabapentin, which comes in tablet form with 600mg and 30 tablets in a container. The manufacturer is Cipla and it's packaged by Contract Pharmacy Services-PA. The lot number is not available but the pill ID is 12 and the expiry date is 04/03/18. The description also includes the dosages and use of the medication. It should be stored at a temperature between 20°-25°C (68°-77°F). The NDC code is 67048-234.30.*

Gabapentin is a prescription-only medication available in a bottle of 30 tablets. Each tablet contains 800mg of gabapentin, USP. To get further details about the drug, refer to the package insert. The medication involves a lot identified as H605341 and packaged by Contract Pharmacy Services-PA. The CPSNDC number for the medication is 67046-238-30. It is advisable to store the medication at temperatures between 20°-25°C (88°-77°F) in a controlled room.*